Conflict of Interest
W., Cancer
ONCOLOGY, CANCER, EMD
Van K. Morris disclosed research funding (to institution) from EMD Serono, Pfizer, Novartis, Bicara Pharmaceuticals, Bristol Myers Squibb, and BioNTech. Benny Johnson reported consulting/advisory relationships with Gritstone Bio, Incyte, Taiho Oncology, and Insmed Oncology, and research funding (to institution) from Bristol-Myers Squibb, Syntrix, and Gateway for Cancer Research. Ryan W. Huey disclosed honoraria from Bayer and Intellisphere, LLC. The other authors indicated no financial relationships.